NASDAQ:LFMD

LifeMD (LFMD) Stock Price, News & Analysis

$10.89
+0.89 (+8.90%)
(As of 04/23/2024 ET)
Today's Range
$10.16
$11.07
50-Day Range
$6.67
$11.53
52-Week Range
$1.40
$12.01
Volume
1.11 million shs
Average Volume
518,141 shs
Market Capitalization
$439.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.40

LifeMD MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
4.5% Downside
$10.40 Price Target
Short Interest
Bearish
8.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.97mentions of LifeMD in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.14) to ($0.31) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.23 out of 5 stars

Medical Sector

903rd out of 910 stocks

Offices & Clinics Of Medical Doctors Industry

7th out of 7 stocks

LFMD stock logo

About LifeMD Stock (NASDAQ:LFMD)

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LFMD Stock Price History

LFMD Stock News Headlines

Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars
Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.
LifeMD Full Year 2023 Earnings: Beats Expectations
Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars
Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.
LifeMD Shares Jump on Strong 4Q
LifeMD Reports Fourth Quarter 2023 Results
Here's what to expect from LifeMD's earnings
Get Your Shopping List Ready: Here's How to Buy Pullbacks
LifeMD Insiders Placed Bullish Bets Worth US$1.24m
Best Iodine Supplements Of 2024
LifeMD Provides 2024 Financial Guidance
See More Headlines
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/11/2024
Today
4/24/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Current Symbol
NASDAQ:LFMD
Fax
N/A
Employees
207
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.40
High Stock Price Target
$14.00
Low Stock Price Target
$7.00
Potential Upside/Downside
-6.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-20,600,000.00
Pretax Margin
-11.41%

Debt

Sales & Book Value

Annual Sales
$152.55 million
Book Value
$0.15 per share

Miscellaneous

Free Float
32,741,000
Market Cap
$439.63 million
Optionable
Optionable
Beta
1.43
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Justin SchreiberMr. Justin Schreiber (Age 41)
    Chairman & CEO
    Comp: $255k
  • Mr. Marc Benathen (Age 43)
    Chief Financial Officer
    Comp: $378.75k
  • Mr. Eric H. Yecies (Age 46)
    Chief Legal Officer, General Counsel & Secretary
    Comp: $332k
  • Ms. Maria E. Stan CPA (Age 49)
    Controller & Principal Accounting Officer
  • Mr. Dennis Wijnker (Age 48)
    Chief Technology Officer
  • Mr. Shane Biffar
    Chief Compliance Officer & Deputy General Counsel
  • Ms. Jessica Friedeman (Age 40)
    Chief Marketing Officer
  • Mr. Stefan GalluppiMr. Stefan Galluppi (Age 37)
    Chief Innovation Officer
    Comp: $165k
  • Mr. Nicholas P. Alvarez (Age 42)
    Chief Acquisition Officer & Head of Customer Acquisition
    Comp: $141.11k
  • Mr. Varun Pathak
    Chief Software Engineer & Co-Founder of PDF Simpli

LFMD Stock Analysis - Frequently Asked Questions

Should I buy or sell LifeMD stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeMD in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LFMD shares.
View LFMD analyst ratings
or view top-rated stocks.

What is LifeMD's stock price target for 2024?

5 Wall Street analysts have issued 12 month price targets for LifeMD's stock. Their LFMD share price targets range from $7.00 to $14.00. On average, they predict the company's stock price to reach $10.40 in the next year. This suggests that the stock has a possible downside of 4.5%.
View analysts price targets for LFMD
or view top-rated stocks among Wall Street analysts.

How have LFMD shares performed in 2024?

LifeMD's stock was trading at $8.29 on January 1st, 2024. Since then, LFMD stock has increased by 31.4% and is now trading at $10.89.
View the best growth stocks for 2024 here
.

Are investors shorting LifeMD?

LifeMD saw a increase in short interest in March. As of March 31st, there was short interest totaling 2,650,000 shares, an increase of 37.3% from the March 15th total of 1,930,000 shares. Based on an average daily volume of 762,800 shares, the days-to-cover ratio is currently 3.5 days. Currently, 8.6% of the shares of the stock are sold short.
View LifeMD's Short Interest
.

When is LifeMD's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our LFMD earnings forecast
.

How were LifeMD's earnings last quarter?

LifeMD, Inc. (NASDAQ:LFMD) posted its quarterly earnings data on Monday, March, 11th. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.02. The firm had revenue of $44.86 million for the quarter, compared to analyst estimates of $40.65 million.

What ETFs hold LifeMD's stock?

ETFs with the largest weight of LifeMD (NASDAQ:LFMD) stock in their portfolio include Invesco DWA SmallCap Momentum ETF (DWAS).Invesco Dorsey Wright Healthcare Momentum ETF (PTH).

What guidance has LifeMD issued on next quarter's earnings?

LifeMD updated its first quarter 2024 earnings guidance on Tuesday, March, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $42.0 million-$43.0 million, compared to the consensus revenue estimate of $42.5 million.

How do I buy shares of LifeMD?

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LFMD) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners